{{Rsnum
|rsid=10932037
|Gene=ICOS
|Chromosome=2
|position=203960623
|Orientation=plus
|GMAF=0.07025
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ICOS
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 71.4 | 26.8 | 1.8
| HCB | 92.7 | 7.3 | 0.0
| JPT | 95.5 | 4.5 | 0.0
| YRI | 89.8 | 10.2 | 0.0
| ASW | 89.5 | 8.8 | 1.8
| CHB | 92.7 | 7.3 | 0.0
| CHD | 90.8 | 9.2 | 0.0
| GIH | 81.2 | 18.8 | 0.0
| LWK | 86.1 | 11.1 | 2.8
| MEX | 86.0 | 12.3 | 1.8
| MKK | 91.7 | 8.3 | 0.0
| TSI | 84.3 | 15.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19175525
|Title=CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data
|OA=1
}}

{{PMID Auto
|PMID=21526489
|Title=ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population
}}

{{PMID Auto
|PMID=21917182
|Title=ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study
|OA=1
}}

{{PMID Auto
|PMID=18200060
|Title=PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
}}

{{PMID Auto
|PMID=19202444
|Title=Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation.
}}

{{PMID Auto
|PMID=24083358
|Title=Effect of Soluble Inducible Costimulator Level and Its Polymorphisms on Age-Related Macular Degeneration
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}